Events

Recall of Moxalactam 30 μg disks for antibiogram

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by BioRad.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2008-01-28
  • Event Country
    France
  • Event Source
    ANSM
  • Event Source URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/retrait-d-un-lot-de-disques-de-moxalactam-30-g-pour-antibiogramme-biorad
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    The Afssaps was informed, on 23/01/2008, of the withdrawal of a batch of Moxalactam 30 μg disks for antibiogram, carried out by BioRad, following antibiotic load adjustments. Users of this device affected by this defect, in France, received the enclosed letter (23/01/2008) (16 KB). This information is intended for laboratory managers, directors of health establishments and local correspondents of reactive vigilance for distribution to the concerned biology departments.

Device

Moxalactam 30 μg disks for antibiogram
  • Model / Serial
  • Product Description
    in-vitro_medical_device
  • Manufacturer
    BioRad

Manufacturer

BioRad